{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:28:36Z","timestamp":1769819316108,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,22]]},"DOI":"10.7759\/cureus.35317","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T18:31:46Z","timestamp":1677090706000},"source":"Crossref","is-referenced-by-count":1,"title":["Atypical Dermatitis Herpetiform and Scalp Psoriasis in Ulcerative Colitis Patient Treated With Adalimumab"],"prefix":"10.7759","author":[{"given":"Hamza","family":"Alshehri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afnan","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abrar","family":"bin Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Adalimumab in rheumatoid arthritis treatment: a systematic review and meta-analysis of randomized clinical trials (Article in Portuguese)","volume":"53","author":"Machado MA","year":"2013","unstructured":"Machado MA, Maciel AA, de Lemos LL, et al.. Adalimumab in rheumatoid arthritis treatment: a systematic review and meta-analysis of randomized clinical trials (Article in Portuguese). Rev Bras Reumatol. 2013, 53:419-30.","journal-title":"Rev Bras Reumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02746","article-title":"Psoriasis: classical vs. paradoxical. The yin-yang of TNF and type I interferon","volume":"9","author":"Mylonas A","year":"2018","unstructured":"Mylonas A, Conrad C. Psoriasis: classical vs. paradoxical. The yin-yang of TNF and type I interferon. Front Immunol. 2018, 9:2746. 10.3389\/fimmu.2018.02746","journal-title":"Front Immunol"},{"key":"ref3","article-title":"Recalcitrant paradoxical pustular psoriasis induced by infliximab: two case reports","volume":"9","author":"Xia P","year":"2021","unstructured":"Xia P, Li YH, Liu Z, Zhang X, Jiang Q, Zhou XY, Su W. Recalcitrant paradoxical pustular psoriasis induced by infliximab: two case reports. World J Clin Cases. 2021, 9:3655-61.","journal-title":"World J Clin Cases"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5455\/medscience.2020.06.116","article-title":"Celiac disease presenting as dermatitis herpetiformis: a case report","volume":"9","author":"Kirik A","year":"2020","unstructured":"Kirik A, Ozcelik S, Altun E, Aslan F, Ucdu GZ, Dogru T. Celiac disease presenting as dermatitis herpetiformis: a case report. Med Sci (Turkey). 2020, 9:1083-5. 10.5455\/medscience.2020.06.116","journal-title":"Med Sci (Turkey)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07682.x","article-title":"Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists","volume":"156","author":"Lee HH","year":"2007","unstructured":"Lee HH, Song IH, Friedrich M, et al.. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol. 2007, 156:486-91. 10.1111\/j.1365-2133.2007.07682.x","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14993","article-title":"Tumor necrosis factor-\u03b1 inhibitor-induced follicular psoriasiform eruption","volume":"39","author":"Goldberger T","year":"2022","unstructured":"Goldberger T, Benshushan S, Davidovics Z, Wilschanski M, Molho-Pessach V. Tumor necrosis factor-\u03b1 inhibitor-induced follicular psoriasiform eruption. Pediatr Dermatol. 2022, 39:598-600. 10.1111\/pde.14993","journal-title":"Pediatr Dermatol"},{"key":"ref7","article-title":"Cutaneous reactions to adalimumab administration","volume":"104","author":"Downes MR","year":"2011","unstructured":"Downes MR, Prendiville S, Kiely C, Lenane P, Mulligan N. Cutaneous reactions to adalimumab administration. Ir Med J. 2011, 104:122-3.","journal-title":"Ir Med J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/039463201202500220","article-title":"Psoriasiform dermatitis in a non-psoriatic patient treated with adalimumab","volume":"25","author":"Tammaro A","year":"2012","unstructured":"Tammaro A, Persechino S, Abruzzese C, Narcisi A, Cortesi G, Parisella FR, Lagan\u00e0 B. Psoriasiform dermatitis in a non-psoriatic patient treated with adalimumab. Int J Immunopathol Pharmacol. 2012, 25:499-501. 10.1177\/039463201202500220","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/09546630902882089","article-title":"Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: a 'class effect' of TNF-alpha antagonists or simply an anti-psoriatic treatment adverse reaction?","volume":"21","author":"Rallis E","year":"2010","unstructured":"Rallis E, Korfitis C, Stavropoulou E, Papaconstantis M. Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: a 'class effect' of TNF-alpha antagonists or simply an anti-psoriatic treatment adverse reaction?. J Dermatolog Treat. 2010, 21:3-5. 10.3109\/09546630902882089","journal-title":"J Dermatolog Treat"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2020.101637","article-title":"Etiopathogenesis of dermatitis herpetiformis","volume":"39","author":"Rybak-d'Obyrn J","year":"2022","unstructured":"Rybak-d'Obyrn J, Placek W. Etiopathogenesis of dermatitis herpetiformis. Postepy Dermatol Alergol. 2022, 39:1-6. 10.5114\/ada.2020.101637","journal-title":"Postepy Dermatol Alergol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/135497-atypical-dermatitis-herpetiform-and-scalp-psoriasis-in-ulcerative-colitis-patient-treated-with-adalimumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:50:25Z","timestamp":1707508225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/135497-atypical-dermatitis-herpetiform-and-scalp-psoriasis-in-ulcerative-colitis-patient-treated-with-adalimumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.35317","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,22]]}}}